Role of immunoglobulin in neuronal apoptosis in a neonatal rat model of hypoxic ischemic brain injury

Experimental and Therapeutic Medicine

Volumn 7, Issue 3, 2014, Pages 734-738

  Kalay, Salih ^a   Öztekin, Osman ^a   Tezel, Gönül ^a   Aldemir, Hakan ^b   Sahin, Emel ^a   Köksoy, Sadi ^a   Akçakuş, Mustafa ^a   Oygur, Nihal ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

^b Anadolu Hastanesi Antalya   (Turkey)

Author keywords

Apoptosis; Cytokine; Hypoxic ischemic encephalopathy; Intravenous immunoglobulin

Indexed keywords

EID: 84892954891     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2014.1470     Document Type: Article

References (33)

1. Volpe JJ: Hypoxic-ischemic encephalopathy: clinical aspects. In: Neurology of the Newborn. 5th edition. WB Saunders, Philadelphia, PA, pp400-480, 2008.
2. Perlman JM: Pathogenesis of hypoxic-ischemic brain injury. JPerinatol 27: S39-S46, 2007.
3. Kapetanakis A, Azzopardi D, Wyatt J and Robertson NJ: Therapeutic hypothermia for neonatal encephalopathy: a UK survey of opinion, practice and neuroinvestigation at the end of 2007. Acta Paediatr 98: 631-635, 2009.
4. Gluckman PD, Wyatt JS, Azzopardi D, Ballard R, Edwards AD, Ferriero DM, et al: Selective head cooling with mild systemic hypothermia after neonatal encephalopathy: multicentre randomised trial. Lancet 365: 663-670, 2005.
5. O'Brien FE, Iwata O, Thornton JS, De Vita E, Sellwood MW, Iwata S, et al: Delayed whole-body cooling to 33 or 35 degreesC and the development of impaired energy generation consequential to transient cerebral hypoxia-ischemia in the newborn piglet. Pediatrics 117: 1549-1559, 2006.
6. Liu Y, Barks JD, Xu G and Silverstein FS: Topiramate extends the therapeutic window for hypothermia-mediated neuroprotection after stroke in neonatal rats. Stroke 35: 1460-1465, 2004.
7. Ma D, Hossain M, Chow A, Arshad M, Battson RM, Sanders RD, et al: Xenon and hypothermia combine to provide neuroprotection from neonatal asphyxia. Ann Neurol 58: 182-193, 2005.
8. Jatana M, Singh I, Singh AK and Jenkins D: Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 59: 684-689, 2006.
9. Kelen D and Robertson NJ: Experimental treatments for hypoxic ischaemic encephalopathy. Early Hum Dev 86: 369-377, 2010.
10. Dammann O and O'Shea TM: Cytokines and perinatal brain damage. Clin Perinatol 35: 643-663, 2008.
11. McAdams RM and Juul SE: The role of cytokines and inflammatory cells in perinatal brain injury. Neurol Res Int 2012: 561494, 2012.
12. Lakhan SE, Kirchgessner A and Hofer M: Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J Transl Med 7: 97, 2009.
13. Durandy A, Kaveri SV, Kuijpers TW, Basta M, Miescher S, Ravetch JV and Rieben R: Intravenous immunoglobulins-understanding properties and mechanisms. Clin Exp Immunol 158 (Suppl 1): 2-13, 2009.
14. Arumugam TV, Tang SC, Lathia JD, Cheng A, Mughal MR, Chigurupati S, et al: Intravenous immunoglobulin (IVIG) protects the brain against experimental stroke by preventing complement-mediated neuronal cell death. Proc Natl Acad Sci USA 104: 14104-14109, 2007.
15. Arumugam TV, Woodruff TM, Lathia JD, Selvaraj PK, Mattson MP and Taylor SM: Neuroprotection in stroke by complement inhibition and immunoglobulin therapy. Neuroscience 158: 1074-1089, 2009.
16. Kalay S, Oztekin O, Tezel G, et al: The effects of intraperitoneal pentoxifylline treatment in rat pups with hypoxic ischemic encephalopathy. Pediatr Neurol 49: 319-323, 2013.
17. Rice JE III, Vannucci RC and Brierley JB: The influence of immaturity on hypoxic-ischemic brain damage in the rat. Ann Neurol 9: 131-141, 1981.
18. VanGuilder HD, Vrana KE and Freeman WM: Twenty-five years of quantitative PCR for gene expression analysis. Biotechniques 44: 619-626, 2008.
19. Leonardo CC and Pennypacker KR: Neuroinflammation and MMPs: potential therapeutic targets in neonatal hypoxic-ischemic injury. J Neuroinflammation 6: 13, 2009.
20. Lai AY and Todd KG: Microglia in cerebral ischemia: molecular actions and interactions. Can J Physiol Pharmacol 84: 49-59, 2006.
21. Yager JY: Animals models of hypoxic-ischemic brain damage in the newborn. Semin Pediatr Neurol 11: 31-46, 2004.
22. Northington FJ, Graham EM and Martin LJ: Apoptosis in perinatal hypoxic-ischemic brain injury: how important is it and should it be inhibited? Brain Res Rev 50: 244-257, 2005.
23. Atici A, Bozlu G, Turhan AH, Polat A, Nayci A, Okuyaz C and Taskinlar H: The role of trapidil on neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Early Hum Dev 84: 243-247, 2008.
24. Bozlu G, Atici A, Turhan AH, Polat A, Nayci A, Okuyaz C and Taskinlar H: Platelet-activating factor antagonist (ABT-491) decreases neuronal apoptosis in neonatal rat model of hypoxic ischemic brain injury. Brain Res 1143: 193-198, 2007.
25. Denker SP, Ji S, Dingman A, Lee SY, Derugin N, Wendland MF and Vexler ZS: Macrophages are comprised of resident brain microglia not infiltrating peripheral monocytes acutely after neonatal stroke. J Neurochem 100: 893-904, 2007.
26. Oygür N, Sönmez O, Saka O and Yeǧin O: Predictive value of plasma and cerebrospinal fluid tumour necrosis factor-alpha and interleukin-1 beta concentrations on outcome of full term infants with hypoxic-ischemic encephalopathy. Arch Dis Child Fetal Neonatal Ed 79: F190-F193, 1998.
27. Foster-Barber A, Dickens B and Ferriero DM: Human perinatal asphyxia: correlation of neonatal cytokines with MRI and outcome. Dev Neurosci 23: 213-218, 2001.
28. Kilpatrick L and Harris MC: Cytokines and the inflammatory response. In: Fetal and Neonatal Physiology. Polin RA, Fox WW and Fletcher J (eds). 2nd edition. WB Saunders, Philadelphia, PA, pp1967-79, 1998.
29. Galasso JM, Wang P, Martin D and Silverstein FS: Inhibition of TNF-alpha can attenuate or exacerbate excitotoxic injury in neonatal rat brain. Neuroreport 11: 231-235, 2000.
30. Chen S, Yang X and Li CR: Immunoglobulin therapy in neonates with hypoxic ischemic encephalopathy. Chin J Pediatr 3: 38-42, 2000 (In Chinese).
31. Dong YN, Zhang QY, Sui ZG, et al: Short term effects of high-dose intravenous immunoglobulin therapy in neonates with hypoxic ischemic encephalopathy. Med J Qilu 1: 23-27, 2006.
32. Toungouz M, Denys CH, De Groote D and Dupont E: In vitro inhibition of tumour necrosis factor-alpha and interleukin-6 production by intravenous immunoglobulins. Br J Haematol 89: 698-703, 1995.
33. Crow AR, Song S, Semple JW, Freedman J and Lazarus AH: A role for IL-1 receptor antagonist or other cytokines in the acute therapeutic effects of IVIg? Blood 109: 155-158, 2007.